Inflammatory factors in major and macular branch retinal vein occlusion

Ophthalmologica

Volumn 227, Issue 3, 2012, Pages 146-152

  Noma, Hidetaka ^a   Funatsu, Hideharu ^a   Mimura, Tatsuya ^b   Eguchi, Shuichiro ^c   Shimada, Katsunori ^d  

^a Tokyo Women s Medical University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Eguchi Eye Hospital   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Branch retinal vein occlusion; Pigment epithelium derived factor; Site of occlusion; Soluble intercellular adhesion molecule 1; Vascular endothelial growth factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; RETINA MACULA EDEMA; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

AGED; EYE PROTEINS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MACULAR EDEMA; MALE; NERVE GROWTH FACTORS; RETINAL VEIN OCCLUSION; SERPINS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 84859001299     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000335047     Document Type: Article

References (22)

1. Gutman FA, Zegarra H: The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 178-192.
2. Orth DH, Patz A: Retinal branch vein occlusion. Surv Ophthalmol 1978; 22: 357-376. (Pubitemid 8384633)
3. Battaglia Parodi M, Saviano S, Bergamini L, Ravalico G: Grid laser treatment of macular edema in macular branch retinal vein occlusion. Doc Ophthalmol 1999; 97: 427-431.
4. Joffe L, Goldberg RE, Magargal LE, Annesley WH: Macular branch vein occlusion. Ophthalmology 1980; 87: 91-98. (Pubitemid 10113532)
5. Lim JW: Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion. Ophthalmologica 2011; 225: 150-154.
6. Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-282.
7. Otani T, Kishi S: Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 2000; 129: 487-494. (Pubitemid 30184920)
8. Saika S, Tanaka T, Miyamoto T, Ohnishi Y: Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 2001; 239: 729-732. (Pubitemid 33061876)
9. Tachi N, Hashimoto Y, Ogino N: Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999; 97: 465-469.
10. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E: Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 2007; 27: 49-54. (Pubitemid 46095830)
11. Battaglia Parodi M, Saviano S, Ravalico G: Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999; 237: 1024-1027. (Pubitemid 30021293)
12. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487. (Pubitemid 24356306)
13. World Health Organization (1999)-International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
14. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK: Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140: 256-261.
15. Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H, Mishima HK: Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006; 244: 309-315.
16. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK: Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008; 22: 42-48.
17. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial. Arch Ophthalmol 1986; 104: 34-41.
18. Noma H, Funatsu H, Mimura T, Eguchi S, Hori S: Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion. Am J Ophthalmol 2011; 152: 69-677 e1.
19. Noma H, Funatsu H, Mimura T, Harino S, Eguchi S, Hori S: Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Graefes Arch Clin Exp phthalmol 2010; 248: 1559-1565.
20. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S: (Pro)renin receptor-mediated signal transduction and tissue reninangiotensin system contribute to diabetesinduced retinal inflammation. Diabetes 2009; 58: 1625-1633.
21. Tomida D, Nishiguchi KM, Kataoka K, Yasuma TR, Iwata E, Uetani R, Kachi S, Terasaki H: Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Invest Ophthalmol Vis Sci 2011; 52: 3193-3199.
22. Robinson R, Ho CE, Tan QS, Luu CD, Moe KT, Cheung CY, Wong TY, Barathi VA: Fluvastatin downregulates VEGF-A expression in TNF-{alpha}-induced retinal vessel tortuosity. Invest Ophthalmol Vis Sci 2011; 52: 7423-7431.